JPRN-UMIN000018913招募中4 期
Effects of SGLT-2 inhibitors for the patients with non-alcoholic fatty liver disease (NAFLD) complicated with type 2 diabetes mellitus. - SGLT-2 and NAFLD/T2DM
Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine0 个研究点目标入组 50 人开始时间: 2015年9月4日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of allergy to SGLT-2 inhibitors 2) HB/HC/autoimmune hepatitis 3) Pregnancy or lactation in women 4) Under insulin treatment 5) Excess alcohol consumption male; >/= 30g/day female; >/= 20g/day 6) Inadequacy for this therapy
研究者
相似试验
进行中（未招募）
1 期
The effects of SGLT2-inhibition in patients with type 2 diabetes and preserved kidney function on renal circulation, kidney function and hormones related to the circulatioType 2 diabetesMedDRA version: 21.1Level: LLTClassification code 10045242Term: Type II diabetes mellitusSystem Organ Class: 100000004861EUCTR2019-004303-12-DKniversity Clinic of Nephrology and Hypertension, Regional Hospital Holstebro20
招募中
不适用
Efficacy and Safety of SGLT2 inhibitors in patients with type 1 diabete.type 1 diabetesJPRN-UMIN000044317Hokkaido University Hospital200
已完成
不适用
Effects of treatment with SGLT2 inhibitor on the initiation of continuous positive airway pressure therapy in type 2 diabetic patients with obstructive sleep apnea syndromeType 2 diabetesJPRN-UMIN000045226Akishima Clinic16
尚未招募
Unknown
Influence of SGLT2 inhibitors on the efficiency of peritoneal dialysisChronic kidney disease under peritoneal dialysisJPRN-UMIN000049848International University of Health and Welfare10
招募中
4 期
Efficacy of SGLT2 inhibitor for Non-Alcoholic Fatty Liver Diseaseon Alcoholic Fatty Liver DiseaseC06.552.241.519C18.452.394.750.149ObesityType 2 Diabetes MellitusRBR-48rxwbCentro Educacional Hyarte